Question 1

What causes infertility?

Accepted Answer

Infertility has many possible causes and often involves more than one factor. In women, the most common contributors are ovulatory disorders (such as polycystic ovary syndrome), tubal disease (often related to prior pelvic infection or surgery), endometriosis, uterine factors such as fibroids or polyps, and age-related decline in egg quantity and quality. In men, low sperm count, reduced motility, abnormal morphology, varicocele, hormonal imbalance, prior infections, and genetic factors are common. In a meaningful share of couples no single cause is identified — this is labeled 'unexplained' infertility and is itself a recognized clinical category. A complete evaluation of both partners is the standard first step before any treatment is considered.

Question 2

What is IVF?

Accepted Answer

In vitro fertilization (IVF) is a multi-step assisted reproductive technique. The ovaries are stimulated with injectable medications to grow multiple follicles; mature eggs are retrieved through a short ultrasound-guided procedure; the eggs are fertilized with sperm in a laboratory (sometimes using ICSI, where a single sperm is injected into each egg); the resulting embryos are cultured for several days; and one embryo is typically transferred to the uterus, with remaining viable embryos frozen for future use. IVF is used for a wide range of indications including tubal disease, severe male-factor infertility, advanced maternal age, unexplained infertility, recurrent pregnancy loss, and certain genetic conditions. It is a medical procedure with defined risks and no guaranteed outcome.

Question 3

How are IVF success rates calculated?

Accepted Answer

Success rates can be reported several different ways and the chosen denominator matters: per cycle started, per egg retrieval, per embryo transfer, clinical pregnancy rate, or live birth rate. Cumulative live birth rate across multiple cycles is generally more informative than a per-cycle figure. Rates should be broken out by patient age (under 35, 35–37, 38–40, 41–42, 43+) and by treatment type (own eggs vs. donor eggs, fresh vs. frozen transfer), because these factors meaningfully change outcomes. In the United States, clinics report standardized data to SART/CDC; in Mexico, national reporting is voluntary, so it is reasonable to ask any clinic how their numbers are measured and to compare like-for-like. No clinic in any country can ethically guarantee pregnancy or live birth.

Question 4

Does age matter for fertility?

Accepted Answer

Yes — age is one of the strongest predictors of fertility outcomes, particularly for women. Egg quantity (ovarian reserve) and egg quality both decline with age, with quality decline becoming more pronounced after the mid-30s and accelerating after age 40. This affects natural conception rates, IVF success rates, miscarriage rates, and chromosomal abnormality rates. Male fertility also changes with age, though more gradually, with measurable effects on sperm DNA integrity and time to pregnancy. Age is not destiny — many people conceive in their late 30s and 40s — but it is an important input into evaluation, expectation-setting, and protocol design. Fertility preservation (egg or embryo freezing) at younger ages is one option some patients choose to discuss with a specialist.

Question 5

What testing is needed for a fertility evaluation?

Accepted Answer

A standard evaluation usually includes a detailed medical and reproductive history, a physical exam, blood work for ovarian reserve and endocrine function (commonly AMH, FSH, LH, estradiol, TSH, and prolactin), pelvic ultrasound to assess the uterus, ovaries, and antral follicle count, and imaging of the uterine cavity and fallopian tubes when appropriate (hysterosalpingogram or sonohysterogram). A semen analysis is the first-line male evaluation and is often repeated to confirm findings. Additional tests — genetic carrier screening, karyotyping, thyroid antibodies, prolactin re-testing, sperm DNA fragmentation, or laparoscopy — may be considered based on history and initial results. Which tests are appropriate is decided by a specialist after personal review.

Question 6

How long does fertility treatment take?

Accepted Answer

Timelines vary by treatment. An ovulation induction or IUI cycle typically runs 2–4 weeks. An IVF cycle from baseline monitoring through egg retrieval is generally 10–14 days of stimulation followed by retrieval, with a fresh transfer 3–5 days later or a frozen transfer planned in a subsequent cycle. Donor-egg cycles are coordinated around the donor's calendar. Frozen embryo transfer cycles usually take 4–6 weeks to prepare the uterine lining and perform the transfer. After transfer, a pregnancy test is performed about 9–14 days later. Many patients require more than one cycle. Building in time between cycles for review, recovery, and protocol adjustments is normal, and your specialist will design a realistic personal timeline.

Question 7

How much can fertility treatment in Mexico cost compared to the US?

Accepted Answer

Public cost reports indicate that standard IVF in Mexico generally runs about 60–75% less than typical US pricing, with comparable savings on IVF with ICSI (60–70%), donor egg IVF (55–70%), and egg freezing cycles (60–75%). For context, a single IVF cycle in the US commonly runs $15,000–$25,000+ before medications, while comparable cycles in Mexico are frequently quoted in the $4,000–$9,000 range. Final cost depends on the protocol your specialist designs, medication dosages, lab procedures (such as embryo culture, ICSI, PGT-A genetic testing, assisted hatching, or embryo freezing and storage), anesthesia, and how many cycles may be required. Quotes can also exclude items like donor compensation, agency fees, or travel and lodging. Because everyone's situation is different, the only reliable number is a personalized, itemized written quote that clearly lists what is and is not included, in what currency, and under what refund or cancellation terms.

Question 8

Are success rates in Mexico comparable to the US?

Accepted Answer

Fertility success depends much more on patient factors — age, ovarian reserve, sperm quality, underlying diagnosis, uterine health, and embryo quality — than on the country where treatment occurs. Laboratory standards, embryologist experience, equipment, and protocol design also matter. US clinics report outcomes annually to the CDC/SART; Mexico does not have an equivalent mandatory national registry, so outcome data is reported voluntarily and can be presented differently. When evaluating any clinic, ask for outcome data broken down by age group (under 35, 35–37, 38–40, 41–42, 43+) and by treatment type (own eggs vs. donor, fresh vs. frozen transfer), plus how those numbers are measured — per cycle started, per egg retrieval, per embryo transfer, or live birth rate. A clinic that openly shares both its strong and its weaker numbers is generally a better sign than one that quotes a single headline figure.

Question 9

Is it safe to travel to Mexico for fertility treatment?

Accepted Answer

Many international patients travel to Mexico for fertility care each year and report positive experiences. Safety is best supported by choosing an internationally accredited hospital (such as one with Joint Commission International accreditation), reviewing the credentials of the physicians and embryology team, verifying the laboratory follows recognized standards for air quality, cryostorage, and embryo handling, receiving a clear written treatment plan and informed-consent documents in advance, and arranging follow-up care with a provider in your home country. From a logistical standpoint, border cities like Tijuana are commonly used by US medical travelers, but it is reasonable to follow your home country's travel advisories, use established transportation, and stay in areas recommended by the clinic. As with any medical procedure, risks exist — including ovarian hyperstimulation syndrome (OHSS), reaction to anesthesia, multiple pregnancy, ectopic pregnancy, and procedural risks — and these should be discussed openly with your specialist before consent.

Question 10

How long are the waiting times?

Accepted Answer

International patients commonly report shorter intake and scheduling timelines in Mexico than in some US systems — often days to a few weeks for an initial consultation rather than months, with retrieval cycles frequently scheduled within 1–3 menstrual cycles of the first consult. Once treatment begins, the clinical timing itself (ovarian stimulation, monitoring, retrieval, embryology, transfer) follows the same biological calendar regardless of country, typically running 2–6 weeks per cycle depending on protocol (antagonist, long agonist, mini-IVF, natural cycle, frozen transfer, etc.). Donor egg cycles and frozen transfers may be coordinated faster because they do not depend on the patient's own cycle timing.

Question 11

How long should I plan to stay in Tijuana?

Accepted Answer

Stay length depends on the treatment plan. A typical IVF stimulation and retrieval visit is roughly 10–14 days from baseline monitoring to retrieval, sometimes followed by a fresh embryo transfer 3–5 days later. Frozen embryo transfer or follow-up visits may only require 2–5 days. Egg freezing usually mirrors the IVF stimulation timeline without the transfer step. Many patients split travel into two shorter trips — one for baseline workup and one for retrieval/transfer — by sharing monitoring (ultrasounds and bloodwork) with a doctor near home. Your specialist will design a personalized timeline based on your protocol and what local monitoring is realistic for you.

Question 12

How do I get to Tijuana from the US?

Accepted Answer

Tijuana is directly accessible from the San Diego area through the San Ysidro and Otay Mesa border crossings, both reachable by car, taxi, or rideshare. Tijuana International Airport (TIJ) is connected to many US cities through the Cross Border Xpress (CBX), a private pedestrian skybridge that lets ticketed passengers walk from a terminal in San Diego directly into TIJ — for many patients this is the simplest route, often faster than driving through the land border. Patients arriving by car should bring a passport, vehicle registration, and Mexican auto insurance (US policies do not cover Mexico). Coordinators can typically assist with airport transfers, lodging suggestions near the hospital, and border logistics.

Question 13

What documents or preparation are needed to travel?

Accepted Answer

US and Canadian citizens generally need a valid passport (or passport card for land crossings) to enter Mexico, and entry as a tourist is typically permitted for short medical stays. Before treatment, patients are usually asked to prepare prior medical records, recent fertility lab work (AMH, FSH, estradiol, TSH, prolactin, and any partner semen analysis), infectious disease screening, recent imaging (such as pelvic ultrasounds or HSG reports), and a current medication and allergy list. Your provider will give a checklist of what to bring, what testing should be repeated locally, and what consent forms must be signed before the cycle starts. Travel insurance that covers medical travel is worth reviewing separately.

Question 14

Are fertility medications included in the quoted cost?

Accepted Answer

Medications are often quoted separately because dosing is highly individualized — based on age, ovarian reserve (AMH and antral follicle count), prior response, and the chosen protocol. A stimulation cycle may use gonadotropins (such as Gonal-F, Menopur, or Follistim), an antagonist or agonist for suppression, and a trigger injection, plus progesterone and estrogen for the luteal phase or transfer. When comparing prices between clinics, always confirm whether the quote includes medications, anesthesia, lab procedures (ICSI, assisted hatching, embryo freezing, PGT-A), embryo storage fees, donor or surrogate fees if applicable, and any follow-up visits. Comparing 'all-in' figures rather than headline prices gives the truest picture, and asking for the quote in writing protects both sides.

Question 15

What about legal and ethical considerations?

Accepted Answer

Mexico has its own legal and regulatory framework for assisted reproduction, which can differ from US state laws in areas like consent, embryo storage and disposition, gamete (egg and sperm) donation, donor anonymity, posthumous reproduction, and surrogacy. Some practices that are legal or restricted in one country may be handled differently in the other. Ask any clinic to explain their informed-consent process, embryo handling and disposition policies (including what happens to unused embryos), donor program rules and screening where applicable, how patient privacy and medical records are protected, and how local regulations are followed. For donor gametes, surrogacy, or cross-border parentage questions, independent legal advice in both Mexico and your home jurisdiction is strongly encouraged before signing any agreement.

Question 16

What happens for follow-up care after I return home?

Accepted Answer

Most international fertility programs offer structured virtual follow-up — for medication guidance, beta hCG monitoring, early pregnancy ultrasounds (typically performed locally and interpreted remotely), thyroid and progesterone monitoring, and ongoing questions during the first trimester. Coordination with a local OB-GYN or reproductive endocrinologist near you is encouraged for any in-person care, especially during early pregnancy and for management of complications such as OHSS, bleeding, or ectopic pregnancy. Ask in advance what follow-up is included in the price, how urgent issues are triaged after hours, how medical records and imaging are shared with your home provider, and what the clinic's policy is if a cycle needs to be repeated.

Question 17

What does an initial fertility evaluation typically include?

Accepted Answer

A standard evaluation generally combines a thorough medical and reproductive history, a physical examination, hormonal blood tests (commonly AMH, FSH, LH, estradiol, TSH, and prolactin), pelvic imaging (transvaginal ultrasound and sometimes a hysterosalpingogram to assess the uterine cavity and fallopian tubes), an ovarian reserve assessment (AMH plus antral follicle count), and a semen analysis for the male partner where applicable. Findings are reviewed in a consultation with a fertility specialist who explains what each result means and what further testing, if any, would be helpful before discussing treatment options.

Question 18

How is ovarian reserve assessed and what does it mean?

Accepted Answer

Ovarian reserve is most commonly estimated using anti-Müllerian hormone (AMH) blood levels combined with antral follicle count (AFC) on transvaginal ultrasound. These measures give a general sense of the remaining quantity of eggs, but they do not measure egg quality, which declines with age independently. Low ovarian reserve does not mean pregnancy is impossible, and normal reserve does not guarantee success — these numbers are one input among many that a specialist uses to design a protocol and discuss realistic expectations.

Question 19

What is ovulation induction and how is it different from IVF?

Accepted Answer

Ovulation induction uses oral medications (such as letrozole or clomiphene) or low-dose injectable hormones to encourage the ovary to release one or more mature eggs, often paired with timed intercourse or IUI. It is generally a first-line option for ovulatory disorders such as PCOS. IVF is a more involved process that uses higher-dose injectable medications to grow multiple follicles, retrieves the eggs surgically, fertilizes them in the laboratory, and transfers an embryo to the uterus. IVF is typically considered when simpler approaches have not worked or when there are factors (tubal disease, severe male factor, advanced age, genetic concerns) that make IVF more appropriate from the start.

Question 20

What are donor egg options and when are they considered?

Accepted Answer

Donor egg treatment uses eggs from a screened donor that are fertilized with the intended father's (or a donor's) sperm and transferred to the recipient's uterus. It may be discussed when ovarian reserve is very low, after repeated IVF cycles with own eggs have not succeeded, after premature ovarian insufficiency, after certain medical treatments that affect the ovaries, or in cases of known heritable genetic conditions. Donor programs typically involve detailed medical, genetic, and psychological screening, plus legal counseling on parentage. Rules around donor anonymity, donor compensation, and recipient eligibility vary by country — ask any clinic to walk through their specific program and applicable regulations.

Question 21

What is fertility preservation and who might consider it?

Accepted Answer

Fertility preservation refers to freezing eggs, sperm, or embryos for potential use in the future. It is most commonly discussed before cancer therapy or other gonadotoxic medical treatments, before gender-affirming care, for genetic conditions affecting fertility, or for individuals who want to defer family-building for personal reasons. Outcomes depend largely on age at the time of freezing and the number of eggs or embryos stored — preservation reduces but does not eliminate the impact of aging on fertility, and no clinic can guarantee a future pregnancy from preserved gametes.

Question 22

How should published success rates be interpreted?

Accepted Answer

Success rates depend on many factors — patient age, diagnosis, ovarian reserve, sperm parameters, embryo quality, uterine health, and the protocol used — so a single headline number rarely tells the full story. Ask whether figures are reported per cycle started, per egg retrieval, per embryo transfer, or as live birth rate, and whether they are broken down by age band (under 35, 35–37, 38–40, 41–42, 43+) and by own-egg vs. donor-egg cycles. Cumulative rates across multiple cycles look different from per-cycle rates. No clinic in any country can ethically guarantee pregnancy or live birth, and a willingness to share both stronger and weaker numbers is generally a healthier sign than a single optimistic statistic.

Question 23

What are the most common medication side effects?

Accepted Answer

Injectable fertility medications can cause bloating, breast tenderness, mood changes, headaches, hot flashes, and local injection-site reactions. Hormonal support (estrogen and progesterone) can cause similar symptoms. Most side effects are mild and resolve after the cycle, but any severe abdominal pain, shortness of breath, rapid weight gain, or significant bleeding should be reported immediately because they can signal ovarian hyperstimulation syndrome (OHSS) or other complications. Your specialist should review the specific medications planned, their side effects, and warning signs before you start.

Question 24

What is OHSS and how is it managed?

Accepted Answer

Ovarian hyperstimulation syndrome (OHSS) is an over-response to fertility medications in which the ovaries become enlarged and fluid can shift into the abdomen. Mild cases are common and resolve on their own; moderate to severe cases (occurring in a small minority of cycles) require closer monitoring or hospitalization and can rarely involve blood-clotting or kidney complications. Modern protocols reduce OHSS risk by using antagonist regimens, GnRH-agonist triggers, lower medication doses for high responders, freezing all embryos and deferring transfer, and careful monitoring with ultrasound and estradiol levels. Ask any clinic how they screen for OHSS risk and how they respond when warning signs appear.

Question 25

What is the risk of multiple pregnancy?

Accepted Answer

Multiple pregnancy (twins or more) is the most common complication of fertility treatment. With IVF, the risk is largely controlled by limiting how many embryos are transferred — elective single embryo transfer (eSET) is the standard for many patients today and dramatically reduces twin and triplet rates. Ovulation induction and IUI carry their own multiple-pregnancy risk that depends on how many follicles mature. Multiple pregnancies are higher risk for both parent and babies (premature birth, preeclampsia, gestational diabetes, NICU admission) and should be discussed openly when deciding transfer strategy.

Question 26

Are there long-term health risks to the patient or future children?

Accepted Answer

Large-scale studies have not shown a meaningfully increased risk of long-term cancer in patients who undergo IVF, though research is ongoing. Children born after IVF have outcomes broadly comparable to naturally conceived children, with a small absolute increase in certain risks (such as preterm birth and low birth weight) that are influenced by underlying parental factors and multiple-pregnancy rates as well as the treatment itself. Specific techniques — ICSI, PGT, donor gametes, surrogacy — each carry their own evidence base. A specialist can walk through the current data in context of your situation.

Question 27

How is emotional well-being supported during treatment?

Accepted Answer

Fertility care can be emotionally demanding, and feelings of grief, anxiety, isolation, relationship strain, or burnout are common and valid. Many programs offer or can refer to counseling with a mental-health professional experienced in reproductive medicine, structured support groups, and educational resources for partners and family. Realistic expectation-setting from the clinical team, transparent communication, and built-in breaks between cycles also help. If you experience symptoms of depression or panic, please seek support from a qualified mental health professional — your fertility team can usually help you find one.

Question 28

How are medical records and personal information kept private?

Accepted Answer

Reputable programs maintain medical records under hospital privacy policies, restrict access to authorized care-team members, use secure systems for sharing imaging and lab results, and require written authorization before releasing records to outside providers. International patients should ask how records are stored, who has access, how communication channels (email, WhatsApp, patient portals) are secured, and how records can be transferred to a provider in their home country for continuity of care.

Question 29

How does international patient coordination usually work?

Accepted Answer

A dedicated coordinator typically guides international patients through scheduling, document collection, pre-cycle testing that can be done locally, travel timing aligned with the cycle calendar, lodging suggestions near the hospital, border-crossing logistics, on-arrival orientation, and post-procedure follow-up after returning home. Bilingual support, secure messaging with the medical team, and a clear point of contact for urgent questions are reasonable expectations. Confirm in advance what is included in coordination versus billed separately, and how time-zone differences are handled.

Question 30

What happens if a cycle doesn't result in pregnancy?

Accepted Answer

Not every cycle leads to pregnancy, and many patients require more than one cycle. After an unsuccessful cycle, the specialist typically reviews what was learned (response to stimulation, egg and embryo quality, lab fertilization, implantation factors) and discusses whether to adjust the protocol, consider additional testing, change strategy (for example, ICSI, PGT, donor gametes, or a different transfer approach), or take a planned break. Clinics should explain in advance their policies on repeat cycles, financial considerations, and how they decide when a different path is more likely to help.

Question 31

Are cost ranges on this site guaranteed or quoted prices?

Accepted Answer

No. Any cost ranges shown on this website are general educational estimates compiled from public sources and intended only for comparison. They are not quotes from any clinic, do not constitute a binding price, and may not reflect your individual situation, the medications you need, or additional services. Always request a personalized written quote from any provider you are considering, in writing, that itemizes what is and is not included, the currency, and refund or cancellation terms.

Question 32

Who may not be an ideal candidate for fertility treatment such as IVF?

Accepted Answer

Candidacy is decided individually by a specialist after a full evaluation, but some situations may make certain treatments inappropriate or require additional steps first. Examples include untreated medical conditions that make pregnancy unsafe (such as poorly controlled cardiac, kidney, liver, autoimmune, thyroid, or oncologic disease), active untreated infections, very low ovarian reserve where own-egg IVF is unlikely to succeed (in which case donor-egg options may be discussed), uterine abnormalities that need surgical correction before transfer, severely abnormal sperm parameters requiring surgical sperm retrieval or donor sperm, untreated mental-health crises, and active substance use that would affect a pregnancy. Lifestyle factors such as significantly elevated or low BMI, heavy smoking, or heavy alcohol use are commonly addressed before treatment because they affect both safety and outcomes. None of these are automatic exclusions — they are reasons for further evaluation, optimization, or an alternative pathway.

Question 33

What treatment alternatives exist besides IVF?

Accepted Answer

Depending on diagnosis and age, reasonable alternatives may include expectant management with timed intercourse, lifestyle and weight optimization, treatment of underlying conditions (thyroid disease, PCOS, endometriosis, fibroids, varicocele), ovulation induction with oral medications such as letrozole or clomiphene, intrauterine insemination (IUI), surgical correction of tubal or uterine factors, donor sperm or donor egg programs, gestational surrogacy where legally available, embryo donation, adoption, or choosing not to pursue treatment. Each option has its own benefits, limitations, costs, success expectations, and emotional considerations. A specialist can outline which alternatives apply to your specific situation.

Question 34

What should I expect during the initial fertility consultation?

Accepted Answer

An initial consultation typically includes a detailed review of medical, reproductive, surgical, family, and lifestyle history for both partners where applicable; review of any prior testing or treatment; a focused physical and pelvic exam; planning of additional diagnostic testing (hormonal labs, ultrasound, HSG, semen analysis); discussion of personal goals and timeline; an open conversation about possible risks and realistic expectations; and an overview of treatment options including alternatives to the most invasive pathways. You should leave the consultation with a clear understanding of next steps and the information you need to decide whether and how to proceed.

Question 35

What does a realistic recovery timeline after egg retrieval look like?

Accepted Answer

Most patients can return to light activity the day after egg retrieval, with bloating, mild cramping, and spotting being common for several days. Strenuous exercise, heavy lifting, and intercourse are typically avoided for one to two weeks to reduce the risk of ovarian torsion and OHSS. Cycles vary, but baseline labs and the next menstrual period generally return within 2–6 weeks. Any severe pain, rapid abdominal swelling, shortness of breath, heavy bleeding, fever, or fainting should prompt immediate contact with the clinical team. Your specialist will give personalized post-procedure instructions based on your protocol and response.

Treatment	Mexico (USD)	United States (USD)	Typical Savings
Standard IVF (own eggs)	$4,000 – $8,000	$15,000 – $25,000+	60–75%
IVF with ICSI	$5,000 – $9,000	$16,000 – $27,000+	60–70%
Donor Egg IVF	$6,500 – $13,000	$25,000 – $40,000+	55–70%
Egg Freezing (one cycle)	$3,500 – $6,500	$15,000+	60–75%

Educational guidance for patients exploring fertility care options in Mexico.

A coordinated, educational approach for international patients

International Patient Support

Coordinated Care

Educational Approach

Treatment Planning

Travel Assistance

Cross-Border Patient Experience

Understanding Fertility

Female fertility

Male fertility

Ovulation

Embryo development

Age-related fertility changes

When to seek evaluation

Common Causes of Infertility

Ovulatory disorders

Tubal disease

Endometriosis

Male factor infertility

Age-related fertility decline

Unexplained infertility

Can Age Affect Fertility?

Why Consider Fertility Treatment in Mexico?

Convenient cross-border access via CBX

Meaningful Cost Differences

Proximity to the United States

Accredited Facilities

Shorter Waiting Periods

International Patient Support

Established Specialty Care

Why Patients Explore Fertility Care in Mexico

Consultation access

International patient coordination

Treatment planning

Follow-up

Understanding Fertility Evaluation

Medical History

Hormonal Testing

Imaging

Semen Analysis

Ovarian Reserve Assessment

Physician Consultation

The Fertility Evaluation Process

Consultation

Hormonal testing

Ultrasound

Semen analysis

Imaging

Genetic testing when appropriate

Educational Cost Ranges: Mexico vs United States

How to Choose a Safe Fertility Provider

JCI Accreditation

Laboratory Standards

Specialist Experience

Success Rate Transparency

Post-Treatment Support

Legal & Ethical Practices

Common Fertility Treatments

IVF — In Vitro Fertilization

ICSI — Intracytoplasmic Sperm Injection

Egg Freezing (Oocyte Cryopreservation)

Embryo Freezing

IUI — Intrauterine Insemination

Preimplantation Genetic Testing (PGT)

Fertility Treatment Pathways

Ovulation induction

Intrauterine insemination (IUI)

In vitro fertilization (IVF)

Intracytoplasmic sperm injection (ICSI)

Egg freezing

Embryo freezing

Donor egg programs

Understanding Success Rates

Understanding IVF Success Rates

Age

Ovarian reserve

Embryo quality

Male factors

Reporting methodology